BMJ Group Retina Logo
BMJ Group Retina Logo

BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought

May be time to reassess use of PARP inhibitor drugs in these patients, say researchers Findings pave way for refining genetic testing and personalised treatment in prostate cancer Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate ...

2025-02-25T17:36:11+00:0025 February 2025|BMJ Oncology, Press release|

Sex-specific panel of 10 proteins can pick up 18 different early stage cancers

Could kickstart new generation of screening tests for early cancer detection, say researchers A sex-specific panel of 10 proteins can pick up 18 different early stage cancers, representing all the major organs of the human body, finds a proof of concept study published in the open access journal BMJ Oncology.  The ...

2024-06-04T10:23:22+00:0010 January 2024|BMJ Oncology, Press release|

Global surge in cancers among the under 50s over past three decades

New cases have risen 79%, overall, with fastest rise in windpipe and prostate cancers Heaviest death toll for cancers of breast, windpipe, lung, bowel, and stomach There’s been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990-2019), ...

2024-06-04T10:23:29+00:007 September 2023|BMJ Oncology, Press release|
Go to Top